Conrad, Curdin http://orcid.org/0000-0002-2547-3440
Ortmann, Christine-Elke
Vandemeulebroecke, Marc
Kasparek, Torben
Reich, Kristian
Clinical trials referenced in this document:
Documents that mention this clinical trial
Lower Limbs are the Most Difficult-to-Treat Body Region of Patients with Psoriasis: Pooled Analysis of CLEAR and CLARITY Studies of Secukinumab Versus Ustekinumab by Body Region
https://doi.org/10.1007/s40259-022-00558-2
Nail Involvement as a Predictor of Differential Treatment Effects of Secukinumab Versus Ustekinumab in Patients with Moderate to Severe Psoriasis
https://doi.org/10.1007/s13555-021-00654-1
Documents that mention this clinical trial
Lower Limbs are the Most Difficult-to-Treat Body Region of Patients with Psoriasis: Pooled Analysis of CLEAR and CLARITY Studies of Secukinumab Versus Ustekinumab by Body Region
https://doi.org/10.1007/s40259-022-00558-2
Nail Involvement as a Predictor of Differential Treatment Effects of Secukinumab Versus Ustekinumab in Patients with Moderate to Severe Psoriasis
https://doi.org/10.1007/s13555-021-00654-1
Funding for this research was provided by:
Novartis Pharma AG
Article History
Received: 27 October 2021
First Online: 6 December 2021